182 related articles for article (PubMed ID: 26141305)
41. 450 IU versus 600 IU gonadotropin for controlled ovarian stimulation in poor responders: a randomized controlled trial.
Lefebvre J; Antaki R; Kadoch IJ; Dean NL; Sylvestre C; Bissonnette F; Benoit J; Ménard S; Lapensée L
Fertil Steril; 2015 Dec; 104(6):1419-25. PubMed ID: 26361207
[TBL] [Abstract][Full Text] [Related]
42. Ovulation triggering with hCG alone, GnRH agonist alone or in combination? A randomized controlled trial in advanced-age women undergoing IVF/ICSI cycles.
Zhou C; Yang X; Wang Y; Xi J; Pan H; Wang M; Zhou Y; Xiao Y
Hum Reprod; 2022 Jul; 37(8):1795-1805. PubMed ID: 35595223
[TBL] [Abstract][Full Text] [Related]
43. [Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].
Ye H; Huang GN; Cao YX; Zhong Y; Huang YH; Zhu GJ; Zhou LM; Chen ZJ; Shi JZ; Zeng Y; Weng N; Huang XF; Yang J; Zhu YM; Li YP; Yi D; Zhuang GL
Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):838-42. PubMed ID: 24444561
[TBL] [Abstract][Full Text] [Related]
44. Cumulative delivery rate per aspiration IVF/ICSI cycle in POSEIDON patients: a real-world evidence study of 9073 patients.
Esteves SC; Yarali H; Vuong LN; Carvalho JF; Özbek İY; Polat M; Le HL; Pham TD; Ho TM; Humaidan P; Alviggi C
Hum Reprod; 2021 Jul; 36(8):2157-2169. PubMed ID: 34179973
[TBL] [Abstract][Full Text] [Related]
45. Transdermal testosterone pretreatment in poor responders undergoing ICSI: a randomized clinical trial.
Bosdou JK; Venetis CA; Dafopoulos K; Zepiridis L; Chatzimeletiou K; Anifandis G; Mitsoli A; Makedos A; Messinis IE; Tarlatzis BC; Kolibianakis EM
Hum Reprod; 2016 May; 31(5):977-85. PubMed ID: 26956551
[TBL] [Abstract][Full Text] [Related]
46. Comparison of a progestin-primed ovarian stimulation protocol with a flexible GnRH antagonist protocol in patients with polycystic ovary syndrome who are participating in an IVF programme: study protocol for a randomised controlled trial.
Wang N; Zhu Q; Ma M; Liang Z; Tao Y; Wang Y; Kuang Y
BMJ Open; 2020 Dec; 10(12):e038153. PubMed ID: 33268401
[TBL] [Abstract][Full Text] [Related]
47. WITHDRAWN: Recombinant versus urinary follicle stimulating hormone for ovarian stimulation in assisted reproduction cycles.
Daya S; Gunby J
Cochrane Database Syst Rev; 2007 Jul; 2006(3):CD002810. PubMed ID: 17636708
[TBL] [Abstract][Full Text] [Related]
48. Efficacy and safety of recombinant human follicle-stimulating hormone in patients undergoing
Hu L; Zhang S; Quan S; Lv J; Qian W; Huang Y; Lu W; Sun Y
Aging (Albany NY); 2020 Mar; 12(6):4918-4930. PubMed ID: 32209728
[TBL] [Abstract][Full Text] [Related]
49. Randomised controlled trial on the effect of clomiphene citrate and gonadotropin dose on ovarian response markers and IVF outcomes in poor responders.
Moffat R; Hansali C; Schoetzau A; Ahler A; Gobrecht U; Beutler S; Raggi A; Sartorius G; De Geyter C
Hum Reprod; 2021 Mar; 36(4):987-997. PubMed ID: 33367742
[TBL] [Abstract][Full Text] [Related]
50. In vitro fertilisation (IVF) versus intracytoplasmic sperm injection (ICSI) in patients without severe male factor infertility: study protocol for the randomised, controlled, multicentre trial INVICSI.
Berntsen S; Nøhr B; Grøndahl ML; Petersen MR; Andersen LF; Englund AL; Knudsen UB; Prætorius L; Zedeler A; Nielsen HS; Pinborg A; Freiesleben NC
BMJ Open; 2021 Jun; 11(6):e051058. PubMed ID: 34168037
[TBL] [Abstract][Full Text] [Related]
51. GnRH Agonist and hCG (Dual Trigger) Versus hCG Trigger for Final Oocyte Maturation in Expected Normal Responders With a High Immature Oocyte Rate: Study Protocol for a Randomized, Superiority, Parallel Group, Controlled Trial.
Yan MH; Cao JX; Hou JW; Jiang WJ; Wang DD; Sun ZG; Song JY
Front Endocrinol (Lausanne); 2022; 13():831859. PubMed ID: 35418945
[TBL] [Abstract][Full Text] [Related]
52. Randomized, active-controlled, comparative phase 3 efficacy and safety equivalence trial of Ovaleap® (recombinant human follicle-stimulating hormone) in infertile women using assisted reproduction technology (ART).
Strowitzki T; Kuczynski W; Mueller A; Bias P
Reprod Biol Endocrinol; 2016 Jan; 14():1. PubMed ID: 26733057
[TBL] [Abstract][Full Text] [Related]
53. Recombinant human luteinizing hormone to trigger ovulation: randomized, controlled, dose-finding pilot study in ovulation induction.
Pierson RA; Olatunbosun OA; Chizen DR; Saunders H; Loumaye E; De Moustier B
J Reprod Med; 2014; 59(7-8):355-66. PubMed ID: 25098025
[TBL] [Abstract][Full Text] [Related]
54. Treatment with the gonadotrophin-releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hormone is effective, safe and convenient: results of a controlled, randomized, multicentre trial. The European Orgalutran Study Group.
Borm G; Mannaerts B
Hum Reprod; 2000 Jul; 15(7):1490-8. PubMed ID: 10875855
[TBL] [Abstract][Full Text] [Related]
55. Individualized versus standard FSH dosing in women starting IVF/ICSI: an RCT. Part 1: The predicted poor responder.
van Tilborg TC; Torrance HL; Oudshoorn SC; Eijkemans MJC; Koks CAM; Verhoeve HR; Nap AW; Scheffer GJ; Manger AP; Schoot BC; Sluijmer AV; Verhoeff A; Groen H; Laven JSE; Mol BWJ; Broekmans FJM;
Hum Reprod; 2017 Dec; 32(12):2496-2505. PubMed ID: 29121326
[TBL] [Abstract][Full Text] [Related]
56. Bioequivalence of recombinant human FSH and recombinant human LH in a fixed 2:1 combination: two phase I, randomised, crossover studies.
Picard M; Rossier C; Papasouliotis O; Lugan I
Curr Med Res Opin; 2008 Apr; 24(4):1199-208. PubMed ID: 18348746
[TBL] [Abstract][Full Text] [Related]
57. The use of recombinant human LH (lutropin alfa) in the late stimulation phase of assisted reproduction cycles: a double-blind, randomized, prospective study.
Tarlatzis B; Tavmergen E; Szamatowicz M; Barash A; Amit A; Levitas E; Shoham Z
Hum Reprod; 2006 Jan; 21(1):90-4. PubMed ID: 16172149
[TBL] [Abstract][Full Text] [Related]
58. Efficacy of recombinant versus human derived follicle stimulating hormone on the oocyte and embryo quality in IVF-ICSI cycles: Randomised, controlled, multi-centre trial.
Abate A; Nazzaro A; Salerno A; Marzano F; Pavone Cossut MR; Perino M
Gynecol Endocrinol; 2009 Aug; 25(8):479-84. PubMed ID: 19572228
[TBL] [Abstract][Full Text] [Related]
59. Safety of Follitropin Alfa/Lutropin Alfa for Stimulation of Follicular Development.
Abramova N; Hubbard J; Schertz J; Richter E
Drug Saf; 2019 Mar; 42(3):453-461. PubMed ID: 30341677
[TBL] [Abstract][Full Text] [Related]
60. Dose adjustment of follicle-stimulating hormone (FSH) during ovarian stimulation as part of medically-assisted reproduction in clinical studies: a systematic review covering 10 years (2007-2017).
Fatemi H; Bilger W; Denis D; Griesinger G; La Marca A; Longobardi S; Mahony M; Yin X; D'Hooghe T
Reprod Biol Endocrinol; 2021 May; 19(1):68. PubMed ID: 33975610
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
